| 000 | 01529 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517054447.0 | ||
| 264 | 0 | _c20160714 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a2152-2669 | ||
| 024 | 7 |
_a10.1016/j.clml.2015.07.632 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRubio-Jurado, Benjamín | |
| 245 | 0 | 0 |
_aCirculating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies. _h[electronic resource] |
| 260 |
_bClinical lymphoma, myeloma & leukemia _cOct 2015 |
||
| 300 |
_a621-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Urokinase Plasminogen Activator _xblood |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTello-González, Alejandra | |
| 700 | 1 | _aBustamante-Chávez, Lili | |
| 700 | 1 | _ade la Peña, Aurora | |
| 700 | 1 | _aRiebeling-Navarro, Carlos | |
| 700 | 1 | _aNava-Zavala, Arnulfo Hernan | |
| 773 | 0 |
_tClinical lymphoma, myeloma & leukemia _gvol. 15 _gno. 10 _gp. 621-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clml.2015.07.632 _zAvailable from publisher's website |
| 999 |
_c25312466 _d25312466 |
||